Insulin and epidermal growth factor receptors in rat liver after administration of the hepatocarcinogen 2-acetylaminofluorene

Ligand binding and autophosphorylation

D. L. Hwang, A. Roitman, B. I. Carr, G. Barseghian, A. Lev-Ran

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The livers of male F344 rats which were fed 0.02% 2-acetylaminofluorene (2-AAF) for two days or more had decreased binding of insulin and epidermal growth factor (EGF) to their hepatic receptors in microsomal and Golgi fractions. Hepatic receptors which were partially purified from carcinogen-fed rats by Triton X-100 solubilization and wheat germ agglutinin affinity column chromatography also had decreased binding activity compared to receptors from normal rats. Scatchard analysis indicated that the decrease in insulin receptor binding was due to decreased receptor number whereas the change in EGF receptor binding was attributed to decreased receptor affinity. Insulin receptor phosphokinase activity was also decreased in 2-AAF-fed rats and correlated with the decrease in receptor binding. EGF receptor phosphokinase activity was unchanged in 2-AAF-fed rats when stimulated with a high concentration (1 μM) of EGF but was decreased when stimulated with low concentrations (0.01-0.1 μM) of EGF. No EGF insulin competing activity for receptor binding was found using acid-ethanol extracts of 2-AAF-altered liver. These results suggest that 2-AAF causes different alterations in the insulin and EGF receptors of the rat liver.

Original languageEnglish
Pages (from-to)1955-1959
Number of pages5
JournalCancer Research
Volume46
Issue number4 II
Publication statusPublished - 1986

Fingerprint

2-Acetylaminofluorene
Epidermal Growth Factor
Insulin
Ligands
Liver
Insulin Receptor
Epidermal Growth Factor Receptor
Phosphotransferases
Wheat Germ Agglutinins
Inbred F344 Rats
Octoxynol
Affinity Chromatography
Carcinogens
Ethanol
rat Egfr protein
Acids

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Insulin and epidermal growth factor receptors in rat liver after administration of the hepatocarcinogen 2-acetylaminofluorene : Ligand binding and autophosphorylation. / Hwang, D. L.; Roitman, A.; Carr, B. I.; Barseghian, G.; Lev-Ran, A.

In: Cancer Research, Vol. 46, No. 4 II, 1986, p. 1955-1959.

Research output: Contribution to journalArticle

Hwang, D. L. ; Roitman, A. ; Carr, B. I. ; Barseghian, G. ; Lev-Ran, A. / Insulin and epidermal growth factor receptors in rat liver after administration of the hepatocarcinogen 2-acetylaminofluorene : Ligand binding and autophosphorylation. In: Cancer Research. 1986 ; Vol. 46, No. 4 II. pp. 1955-1959.
@article{895435466c894f78871a47e69be53f85,
title = "Insulin and epidermal growth factor receptors in rat liver after administration of the hepatocarcinogen 2-acetylaminofluorene: Ligand binding and autophosphorylation",
abstract = "The livers of male F344 rats which were fed 0.02{\%} 2-acetylaminofluorene (2-AAF) for two days or more had decreased binding of insulin and epidermal growth factor (EGF) to their hepatic receptors in microsomal and Golgi fractions. Hepatic receptors which were partially purified from carcinogen-fed rats by Triton X-100 solubilization and wheat germ agglutinin affinity column chromatography also had decreased binding activity compared to receptors from normal rats. Scatchard analysis indicated that the decrease in insulin receptor binding was due to decreased receptor number whereas the change in EGF receptor binding was attributed to decreased receptor affinity. Insulin receptor phosphokinase activity was also decreased in 2-AAF-fed rats and correlated with the decrease in receptor binding. EGF receptor phosphokinase activity was unchanged in 2-AAF-fed rats when stimulated with a high concentration (1 μM) of EGF but was decreased when stimulated with low concentrations (0.01-0.1 μM) of EGF. No EGF insulin competing activity for receptor binding was found using acid-ethanol extracts of 2-AAF-altered liver. These results suggest that 2-AAF causes different alterations in the insulin and EGF receptors of the rat liver.",
author = "Hwang, {D. L.} and A. Roitman and Carr, {B. I.} and G. Barseghian and A. Lev-Ran",
year = "1986",
language = "English",
volume = "46",
pages = "1955--1959",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "4 II",

}

TY - JOUR

T1 - Insulin and epidermal growth factor receptors in rat liver after administration of the hepatocarcinogen 2-acetylaminofluorene

T2 - Ligand binding and autophosphorylation

AU - Hwang, D. L.

AU - Roitman, A.

AU - Carr, B. I.

AU - Barseghian, G.

AU - Lev-Ran, A.

PY - 1986

Y1 - 1986

N2 - The livers of male F344 rats which were fed 0.02% 2-acetylaminofluorene (2-AAF) for two days or more had decreased binding of insulin and epidermal growth factor (EGF) to their hepatic receptors in microsomal and Golgi fractions. Hepatic receptors which were partially purified from carcinogen-fed rats by Triton X-100 solubilization and wheat germ agglutinin affinity column chromatography also had decreased binding activity compared to receptors from normal rats. Scatchard analysis indicated that the decrease in insulin receptor binding was due to decreased receptor number whereas the change in EGF receptor binding was attributed to decreased receptor affinity. Insulin receptor phosphokinase activity was also decreased in 2-AAF-fed rats and correlated with the decrease in receptor binding. EGF receptor phosphokinase activity was unchanged in 2-AAF-fed rats when stimulated with a high concentration (1 μM) of EGF but was decreased when stimulated with low concentrations (0.01-0.1 μM) of EGF. No EGF insulin competing activity for receptor binding was found using acid-ethanol extracts of 2-AAF-altered liver. These results suggest that 2-AAF causes different alterations in the insulin and EGF receptors of the rat liver.

AB - The livers of male F344 rats which were fed 0.02% 2-acetylaminofluorene (2-AAF) for two days or more had decreased binding of insulin and epidermal growth factor (EGF) to their hepatic receptors in microsomal and Golgi fractions. Hepatic receptors which were partially purified from carcinogen-fed rats by Triton X-100 solubilization and wheat germ agglutinin affinity column chromatography also had decreased binding activity compared to receptors from normal rats. Scatchard analysis indicated that the decrease in insulin receptor binding was due to decreased receptor number whereas the change in EGF receptor binding was attributed to decreased receptor affinity. Insulin receptor phosphokinase activity was also decreased in 2-AAF-fed rats and correlated with the decrease in receptor binding. EGF receptor phosphokinase activity was unchanged in 2-AAF-fed rats when stimulated with a high concentration (1 μM) of EGF but was decreased when stimulated with low concentrations (0.01-0.1 μM) of EGF. No EGF insulin competing activity for receptor binding was found using acid-ethanol extracts of 2-AAF-altered liver. These results suggest that 2-AAF causes different alterations in the insulin and EGF receptors of the rat liver.

UR - http://www.scopus.com/inward/record.url?scp=0022624942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022624942&partnerID=8YFLogxK

M3 - Article

VL - 46

SP - 1955

EP - 1959

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 4 II

ER -